A detailed history of Jane Street Group, LLC transactions in Journey Medical Corp stock. As of the latest transaction made, Jane Street Group, LLC holds 18,599 shares of DERM stock, worth $130,750. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,599
Previous 18,599 -0.0%
Holding current value
$130,750
Previous $109,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

BUY
$3.66 - $6.54 $68,072 - $121,637
18,599 New
18,599 $109,000
Q4 2023

Feb 14, 2024

BUY
$2.7 - $7.96 $74,922 - $220,882
27,749 New
27,749 $159,000

Others Institutions Holding DERM

About Journey Medical Corp


  • Ticker DERM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 11,596,500
  • Market Cap $81.5M
  • Description
  • Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...
More about DERM
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.